GlassScriptPhysician profile
Rumman A Syed
NPI 1669995841
$9,490.00
in general payments reported to CMS, 2019-2025
27 companies · $3,987 in 2025
The $3,987 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.25 · 2020: $368 · 2021: $1,149 · 2022: $931 · 2023: $1,961 · 2024: $1,080 · 2025: $3,987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,624 · Travel and Lodging: $2,132 · Education: $273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,623.83 |
| Travel and Lodging | $2,131.56 |
| Education | $273.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,806.04 | 2024-2025 | Watchman Access System, General - Therapies, Opticross |
| Janssen Pharmaceuticals, INC | $1,181.97 | 2021-2024 | Xarelto |
| Medtronic, INC. | $1,086.15 | 2024-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Abbott Laboratories | $849.02 | 2021-2025 | Cardiomems, Portico, Aveir |
| W. L. Gore & Associates, INC. | $687.64 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viatorr Tips Endoprosthesis, Viatorr Endoprosthesis |
| Shockwave Medical, INC | $578.59 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $567.46 | 2021-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $522.59 | 2020-2023 | Farxiga, Brilinta |
| E.R. Squibb & Sons, L.L.C. | $391.27 | 2021-2023 | Camzyos |
| Pfizer INC. | $272.08 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $244.09 | 2021-2024 | Verquvo |
| Abiomed | $216.09 | 2023-2025 | Impella |
| Astellas Pharma US INC | $212.46 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $180.16 | 2023-2024 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $125.00 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $124.77 | 2021 | |
| Chiesi USA, INC. | $116.38 | 2023 | Kengreal |
| Biotronik INC. | $114.83 | 2021 | |
| United Therapeutics Corporation | $31.17 | 2021 | |
| Teleflex LLC | $28.81 | 2023 | Vascband |
| Daiichi Sankyo INC. | $28.60 | 2023 | Injectafer |
| Exelixis INC. | $24.42 | 2020 | |
| Bracco Diagnostics INC. | $24.08 | 2022 | |
| Biosense Webster, INC. | $22.46 | 2024 | Carto 3 |
| Global Blood Therapeutics, INC. | $21.31 | 2021 | |
| Spectrawave, INC | $19.31 | 2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| Genentech USA, INC. | $13.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rumman Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.